ask="18.50"
ask_size="100"
average_daily_volume="319429"
bid="16.36"
bid_size="200"
book_value="3.21"
change="+0.79"
change_from_200_day_moving_average="5.18"
change_from_50_day_moving_average="0.73"
change_from_52_week_high="-5.04"
change_From_52_week_low="13.39"
change_in_percent="+4.58%"
close="18.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7736000"
high="18.06"
high_52_weeks="23.07"
last_trade_date="2/1/2017"
last_trade_price="18.03"
last_trade_size="3894"
last_trade_time="4:00pm"
low="17.34"
low_52_weeks="4.64"
market_capitalization="179.45M"
moving_average_200_day="12.85"
moving_average_50_day="17.30"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="17.38"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+40.32%"
percent_change_from_50_day_moving_average="+4.24%"
percent_change_from_52_week_high="-21.84%"
percent_change_from_52_week_low="+288.58%"
previous_close="17.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.37"
price_per_sales="3035.70"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="7.19"
stock_exchange="NGM"
symbol="ZYNE"
volume="365765"
weeks_range_52="4.64 - 23.07"
